Feline lower urinary tract disease

Triple Crown Urology Opens in Hot Springs, Arkansas, and Joins American Oncology Network

Retrieved on: 
Friday, September 1, 2023

HOT SPRINGS, Ark., Sept. 01, 2023 (GLOBE NEWSWIRE) -- American Oncology Network (AON) is pleased to announce the opening of its first urology practice, Triple Crown Urology .

Key Points: 
  • HOT SPRINGS, Ark., Sept. 01, 2023 (GLOBE NEWSWIRE) -- American Oncology Network (AON) is pleased to announce the opening of its first urology practice, Triple Crown Urology .
  • Triple Crown Urology serves southwest Arkansas with clinics in Hot Springs, Hot Springs Village, Camden, Mena, Benton and Arkadelphia.
  • By joining AON as a partner practice, Triple Crown Urology will not only be able to continue providing urology care and services but also have access to additional resources that elevate patient care.
  • “Triple Crown Urology offers advanced and innovative urology treatments and delivers care that is high quality and patient centered.

LexaGene Completes Analytical Studies for FDA EUA of COVID-19 Testing

Retrieved on: 
Monday, October 25, 2021

LexaGene is in the process of completing the necessary work to have the FDA rule on authorizing the MiQLab for COVID-19 testing.

Key Points: 
  • LexaGene is in the process of completing the necessary work to have the FDA rule on authorizing the MiQLab for COVID-19 testing.
  • The following analytical studies were completed using multiple MiQLab Systems:
    Dr. Regan continued, This milestone should be viewed as having much broader implications than COVID-19 testing only.
  • Preparing our technology to be able to successfully collect the analytical COVID-19 data is arguably the hardest step in the EUA process.
  • Until the FDA grants LexaGenes system EUA for COVID-19 testing, all work using LexaGene instruments is classified as Research Use Only and cannot be used for human clinical diagnostics.

The Worldwide Cystoscope Industry is Expected to Reach $791 Million by 2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 25, 2021

The company had announced that it would launch a novel single-use, sterile, and high-resolution cystoscope in the year 2022.

Key Points: 
  • The company had announced that it would launch a novel single-use, sterile, and high-resolution cystoscope in the year 2022.
  • These trends and developments are expected to play a major role in the market growth, during the forecast period.
  • The growth in the global cystoscope market may be attributed to the rising prevalence of urinary tract diseases globally.
  • These trends are expected to accelerate the demand for novel cystoscope devices and applications, in the coming years.